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To investigate the feasibility of thoracoscopic resection, a pilot study was performed in patients with
clinically resectable lung tumors. In 40 patients, Video-assisted thoracic surgery (VATS) was per-
formed because of suspicion of malignancy. There were 29 men and 11 women with a median age of
54.8 years (range 18 to 78). Preoperative indications were suspected lung cancer and tumor in 27 pa-
tients, assessment of tumor resectability in 7 patients, and probability of metastatic tumors in 6 pa-
tients. The final diagnoses in the 27 patients with suspected lung cancer were 12 primary lung cancers,
6 lung metastases, and 9 benign lesions. The success rates forVATS (no conversion to thoracotomy)
were of 12 (8.3%) for resectable stage lung cancer, 8 of 12 (66.7%) for metastatic tumors, and 9
of9 (100%) for benign tumors. With VATS, 6 of7 patients (85.7%), possible stage III non-small cell
lung cancer, an explorative thoracotomy with was avoided, significantly reducing morbidity. The rea-
sons for conversion to thoracotomy were 1) oncological (N2 lymph node dissection and prevention
of tumor spillage) and 2) technical (inability to locate the nodule, central localization, no anatomical
fissure, or poor lung function requiring full lung ventilation). The ultimate diagnoses were 19 lung
cancers, 12 metastatic lung tumors, and 9 benign lung tumors. Our data show the limitations ofVATS
for malignant tumors in general use. These findings, together with the fact that experience in per-
forming thoracoscopic procedures demonstrates a learning curve, may limit the use of thoracoscopic
resection as a routine surgical procedure, especially when strict oncological rules are respected.
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INTRODUCTION
Thoracoscopy has been performedby pulmonologists and
thoracic surgeons formore than 80 years. In 1910 the first
thoracoscopy was performed by H. C. Jacobaeus, using a
modified cystoscope, Initially, thoracoscopywas used for
diagnostic purposes in the parietal pleura, diaphragm,
pericardium, mediastinum, and most of the lung.2, Then,
therapeutic applications, such as talc poudrage, fora spon-
taneous pneumothorax became possible. But interest in
thoracoscopy decreased due to the development of safer
operative techniques and the introduction of antitubercu-
lous drugs.
Inthe 1970s, new interest in thoracoscopy emerged due
to the development of video imaging technology and new
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endoscopic instruments. In 1980 Boutin organized the
First International Symposium on Thoracoscopy.4 Many
thoracic surgeons have since extended the applications of
this procedure to include therapeutic interventions such
as mechanical pleurodesis, pleurectomy, bullectomy for
pneumothorax, wedge resection, lobectomy and medi-
astinal mass exploration, and resection forbenign and ma-
lignant tumors.2-3 Even pneumonectomy has been
reported to be feasible. 14,5
Forresectable lung tumors, surgery is the first treatment
of choice. However, the morbidity for thoracotomy is
considerable.6 Thoracoscopic lobectomy may improve
postoperative recovery and reduce the period of hospital-
ization, which may decrease health care costs.
At present, many surgeons are interested in thoraco-
scopic lobectomy for lung cancer, but its efficacy has not
been clearly demonstrated.5-9, 4, 5,17-23 Two major issues
are important: the risk of inadequate nodal staging, re-152 H. SAKAI et al.
suiting in residual tumor, and possible incomplete resec-
tion and tumor spillage.24
To investigate the feasibility of thoracoscopic lobec-
tomy, a pilot study was performed using video-assisted
thoracoscopic surgery (VATS) in 40 patients with clini-
cally resectable lung tumors, with the use of anterior util-
ity thoracotomy.
MATERIALS AND METHODS
Patients
Forty patients with suspected malignant lung tumors were
entered into this study. There were 29 men and 11 women,
and the median age was 54.8 years (range 18 to 78).
Preoperative diagnoses were tumors suspected to be ma-
lignant in 27 patients and probable metastatic lung lesions
in 6 patients; in another7 patients with advanced lung can-
cer, thoracoscopy was used to assess the resectability of
the tumor (Fig. 1).
Pretreatment Investigation
The standard work-up procedure for clinical staging of
lung cancer was performed including chest X-rays, com-
puted tomographic scans of the lung and mediastinum,
bronchoscopy, and lung function studies.
Surgical Procedure
VATS was performed under general anesthesia with adou-
ble lumen tube to collapse the ipsilateral lung. The patient
was placed in the lateral position to prepare for a possible
thoracotomy. In most patients, three trocars (sixth inter-
costal middle axillary line, fourth intercostal anterior, and
posterior axillary lines) were introduced to examine, dis-
sect, and finally resect the tumor. An anterior utility tho-
racotomy (3 to 10 cm) was performed to aid the
thoracoscopic procedure for dissection and removal ofthe
resected specimens when necessary.
RESULTS
Resection of four of six lung tumors suspected of being
metastatic was performed thoracoscopically. In the other
two patients, a conversion to thoracotomy was necessary
(Fig. 1).
In 27 patients with probable primary lung tumors, re-
section of the lesion was performed by VATS in 14. In 13
patients a conversion to thoracotomy was necessary. Final
diagnoses in these patients were 12 primary lung cancers,
6 lung metastases, and 9 benign lesions.
All conversions to a thoracotomy were in patients with
malignant lesions; 11 with primary lung tumors and2 with
lung metastases. This means that in only of 12 patients
with lung cancer was VATS possible. This patient had
stage I disease. The other 11 patients had stage I (n 7),
stage II (n 1), and stage IliA (n 3) disease. The rea-
sons for conversion both for patients with lung metastasis
(4 of 12) and lung cancer (11 of 12) are described in Table
1. According to our data, conversion to thoracotomy oc-
curred in 7 of 11 patients due to technical difficulties (no
anatomical fissure in 1, impossible to find the nodule
and/or centrally located in 5, and poor lung function re-
quiring whole lung ventilation in 1) (Table 1). In another
4 patients conversion to thoracotomy occurred due to de-
finitive N2 positive in and to prevent tumor spill in 3
(Table 1).
The success rates forVATS were of 12 (8.3%) for lung
cancers, 8 of 12 (66.7%) for metastatic lung tumors, and
9 of 9 (100%) for benign lung tumors.
With VATS, in 6 of 7 (85.7%) patients with possible
stage III non-small cell lung cancer, an explorative thora-
cotomy was avoided. Reasons for inoperability were N2
positive tumor. (3 patients), N3 positive tumor (1 patient),
and 14 tumor (2 patients) (Fig. 2).
The overall duration of thoracoscopic lobectomy was
3.5 hours. The duration for metastatectomy was 1.8 hours
and resection of benign lung tumors was 1.3 hours.
DISCUSSION
Twelve of40 patients in whom VATS was performed had
clinicallyresectable non-small cell lung cancers.We could
perform thoracoscopic lobectomy in only patients (1 of
12 8.3%). Hazelrigg et al.22 reported in theirVATS study
group data that in439 patients (439 of 1820 24.1%)even-
tual conversion to a thoracotomy occurred. Video-assisted
lobectomy was reported in 38 patients and 91 patients un-
derwent lobectomy by thoracotomy after a VATS proce-
dure.22 The success rate for thoracoscopic lobectomy was
therefore 38/(38 + 91 29.5%). But it is unclear in how
many patients conversion to wedge resection or pneu-
monectomy occurred or how many tumors turned out to
be inoperable. The success rate for thoracoscopic lobec-
tomy must therefore be less than 29.5%.
Hazelrigg et al.22 also described their inability to find
the lung tumor as a frustrating problem. This occurred in
7.5% of patients, resulting in thoracotomy. In our pilot
study, this was the reason for conversion in 4 of 33 (12%)
patients. In another 3 patients conversion to thoracotomy
was due to technical difficulties (no anatomical fissure,
centrally located nodule, or poor lung function requiring
whole lung ventilation in patient) (Table 1). Many tumorVATS FOR RESECTABLE LUNG TUMORS 153
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Figure I VATS in patients with clinically resectable lung tumors. In 40 patients, VATS were performed for suspected malignant lung tumors. The
success rate forVATS (no conversion to thoracotomy) in clinically resectable non-small cell lung cancers was 8.3%. VATS prevented explorative tho-
racotomies in 85.7% of the patients, significantly reducing morbidity.
Table 1 Reasons for Conversion to Thoracotomy
NSCLC MLT BLT Total
N2 positive
Prevent tumor spill 3 4 7
Nodule not found 4 4
Centrally located
No fissure
Poor lung function
VATS 8 9 18
Total 12 12 9 33
NSCLC, non-small cell lung cancer; MLT, metastatic lung tumor; BLT, benign
lung tumor.
localization techniques have been published in which wire
localization and endoscopic ultrasound seemed to be
somewhat usefulzS,z6 (Fig. 3). It is very important, how-
ever, to apply oncological principles in thoracoscopic re-
section of malignancies.
Our data clearly show the limitations of VATS for ma-
lignant tumors in general. This is in contrast with the more
optimistic results of proponents of thoracoscopic resec-
tion as previously reported, in which patient selection may
influence the success rate of the thoracoscopic approach.
VATS did prevent explorative thoracotomies in 85.7%
of the patients, significantly reducing morbidity.
Therefore, thoracosopic resection of malignancies is ex-
pected to be of only limited usefulness in patients with
clinically resectable malignant pulmonary nodules.
These findings together with the fact that thoracoscopic
procedures demonstrate a learning curve may limit their
use as routine surgical procedures for lobectomy in the154 H. SAKAI et al.
Figure 2 With VATS, we diagnosed N2 positivity, which was not diagnosed before operation. An explorative thoracotomy was avoided in 85.7% of
patients.
Figure 3 Many tumor localization techniques have been published. We tried to localize the tumor with endoscopic ultrasound.
suspicion of a malignancy, especially if strict oncological
rules are followed.
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